Table 3.
Base Case Incremental Cost-Effectiveness Ratios for Six Screening Strategies
| Screening strategy | QALYs/person | Costs/person | ΔCosts | ΔQALYs | ICERs (ΔCosts/ΔQALYs) |
|---|---|---|---|---|---|
| Annual screening, starting at age 50 | 18.2993 | $1762 | $478 | 0.0041 | $116,640 |
| Annual screening, starting at age 60 | 18.2952 | $1284 | – | – | WD* |
| Screening every 2 years, starting age 50 | 18.2952 | $1279 | $238 | 0.0035 | $67,970 |
| Screening every 2 years, starting age 60 | 18.2917 | $1046 | $109 | 0.0041 | $26,503 |
| Screening every 5 years, starting age 50 | 18.2889 | $988 | – | – | WD* |
| Screening every 5 years, starting at age 60 | 18.2876 | $937 | $168 | 0.0065 | $25,915 |
| No screening | 18.2811 | $769 | – | – | – |
*Weak dominance (WD): an alternate strategy is both more effective (higher QALYs) and has a lower ICER